Published: Journal of Analytical Toxicology, Volume 22, Number 1, January/February 1998, pp. 45–49.
Presence of
Phenylethylamine in Hallucinogenic Psilocybe Mushroom: Possible
Role in Adverse Reactions
O. Beck, A.
Helander, C. Karlson-Stiber, and N. Stephansson
The use of mushrooms containing the hallucinogenic substance psilocybin for intentional intoxication is relatively common. Occasionally, this results in adverse reactions with typical tachycardia that is not evidently caused by psilocybin. This study demonstrates the presence of phenylethylamine in the species Psilocybe semilanceata using gas chromatography–mass spectrometry and shows that the amount of this substance may vary much more than that of psilocybin. The highest amount of phenylethylamine (146 µg/g wet weight) was observed in mushrooms from a case of three young men hospitalized because of adverse reactions. Comparison of the symptoms observed in clinical cases of magic mushroom intoxication with those after intake of pure psilocybin or phenylethylamine suggests that phenylethylamine might have a role in the development of adverse reactions to Psilocybe mushroom intake.
Reproduction of editorial content of this journal is prohibited without publisher’s permission.
| This article is available in its entirety by fax for $4.00 per page. Visa or MasterCard accepted. To order electronically click here Please indicate JAT volume and issue along with page numbers. |
| Subscribe | Current Issue | Back Issues | Search | Advertise | Other Publications |